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Introduction
Available treatment options for
patients diagnosed with cancer
include surgery, the administration
of chemotherapeutic agents,
radiation therapy, or a combination
of these modalities.
Chemotherapeutic agents utilized to
treat cancer have a variety of
potential side effects. One of the
most common and well known side
effects associated with the
administration of chemotherapeutic
agents is neutropenia. An estimated
60,000 cancer patients require
hospitalization each year due to
chemotherapy induced neutropenia
related to standard treatment
regimens (Demshar, Vanek, &
Mazanec, 2011). While the criteria
defining neutropenia varies among
institutions, neutropenia may
typically be defined as an absolute
neutrophil count (ANC) less than
1500 cells per microliter with severe
neutropenia defined as an ANC less
than 500 cells per microliter (White
& Ybarra, 2014). Neutropenia places
oncology patients at an increased
risk of contracting infections which
may lead to a life threating
complication known as sepsis.
Sepsis is an extremely dangerous
oncologic emergency requiring
prompt medical treatment. Failure
to recognize symptoms associated
with sepsis in the neutropenic
patient and initiate appropriate
medical treatment significantly
increases the risk of patient
mortality. White and Ybarra (2014)
explain that the mortality risk in
neutropenic patients with
uncontrolled infection varies
inversely with the severity of
neutropenia; therefore, the morality
risk in patients with an ANC less
than 500 cells per microliter is
markedly increased. The aim of this
research project is to aid in further
educating health care professionals
on the pathophysiological process
and implications for nursing
practice associated with caring for
patients with chemotherapy induced
neutropenia and their increased risk
for sepsis.

Underlying Pathophysiology
•

•

•

•

In healthy individuals, the
immune process is well regulated
and the balance between
counteracting forces maintains a
localized inflammatory response
to the area of initial insult (Laszlo,
Trasy, Molnar, and Fazakas,
2015).
Important phagocytic cells of the
innate immune system, including
neutrophils, are produced from
multipluripotent stem cells
within the bone marrow
throughout the lifespan (HeldWarmkessel, 2011; Kovach &
Standiford, 2012).
Neutrophils are released into the
blood stream from the bone
marrow as fully mature cells and
circulate throughout the system
where they adhere to the
endothelial wall and move to the
site of an infection (Kovach &
Standiford, 2012; Vioral &
Wentley, 2015).
Neutrophils are the first
phagocytic cell to arrive at the site
of an infection, function to fight
against bacterial infections, guard
against progression of infection,
and produce common signs and
symptoms of an infection
including redness, swelling, and
purulent drainage (HeldWarmkessel, 2011; Vioral &
Wentley, 2015).

•

•

•

•

Neutrophils play an important role
in the inflammatory response by
releasing crucial regulatory
cytokines, chemokines, and
leukotrienes (Kovach & Standiford,
2012).
The administration of
chemotherapeutic medications for
the treatment of cancer carries
profound effects on the function of
the human immune system.
Chemotherapeutic agents cause
overwhelming destruction in bone
marrow cells, particularly those that
are in the reproductive phase, thus
killing the cells and delaying the
production and turnover of new,
mature phagocytic cells (HeldWarmkessel, 2011).
The interval of time in which the
patient’s cell count is at its lowest is
referred to as the nadir period and
during this time, the patient is at the
greatest risk for infection (HeldWarmkessel, 2011).
Profound localized infections may
spread systemically resulting in
sepsis when the patient’s remaining
mature neutrophils fail to
appropriately phagocytize and
annihilate invading microorganisms
(Held-Warmkessel, 2011).

Significance of Pathophysiology
Bone marrow suppression and subsequent neutropenia significantly increases a
patient’s risk for bacterial infections that can rapidly progress to sepsis (Legrad et al.,
2012). Sepsis may be defined as “…a progressive, injurious, inflammatory response
to overwhelming infection associated with tissue hypoperfusion and multiorgan
dysfunction” (Kovach & Standiford, 2012, p. 321). Deficiency in the number of
functioning neutrophils increases sepsis-mediated morbidity and mortality further
emphasizing the consequences related to alterations in neutrophil response (Kovach
& Standiford, 2012). Kovach and Standiford (2012) further argued that impaired
neutrophil function leads to defective innate immunity culminating in septic patients.

•

•

Signs and Symptoms
•

•

•
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Implications for Nursing Practice

Patients with neutropenia do not
produce a sufficient number of
mature neutrophils to mount an
appropriate immune response
against microorganism invasion
(Vioral & Wentley, 2015).
Therefore, neutropenic patients do
not always present with classic
signs and symptoms of infection.
Often, the earliest and only
response to an infection in the
neutropenic patient is a fever
(Bow, 2013). A single oral
temperature greater than 101
degrees Fahrenheit or a persistent
(longer than one hour) oral
temperature of 100.4 degrees
Fahrenheit represents a fever in a
patient with neutropenia (Vioral &
Wentley, 2015). In patients with
severe neutropenia, there may be
substantial difficulty producing an
immune response. Fever may not
be exhibited and the patient may
present with a temperature that is
below normal, namely
temperatures below 96.8 degrees
Fahrenheit (Bow, 2013; O’Leary,
2014).
The patient may also display
alterations in vital signs, indicating
progression towards sepsis and the
presence of a systemic
inflammatory response. Criteria
concerning for the presence of
systemic inflammatory response
include elevated or subnormal
temperatures, heart rate greater
than ninety beats per min, or a
respiratory rate greater than
twenty breaths per minute (Bow,
2013; O’Leary, 2014). Additionally,
patients may rapidly develop
symptoms of hypotension, altered
mental status, and rigors
(Demshar, et al., 2011).

•

•

•

Altered laboratory values such as a
white blood cell (WBC) count less than
4000 cells/mm3, less than ten percent
band forms in the leukocyte differential
count, and an ANC less than 1500 cells
per microliter are also present (Bow,
2013; O’Leary, 2014).
Patients with neutropenia often
demonstrate infections involving the
respiratory, gastrointestinal,
genitourinary, and integumentary
systems. Vioral and Wentley (2015)
reported that assessment for abnormal
breath sounds related to respiratory
infections is critical as neutropenic
patients with pneumonia do not always
develop cough or sputum. Neutropenic
patients presenting with complaints of
abdominal pain and diarrhea should
raise concerns for gastrointestinal
infections such as Clostridium difficile
(Vioral & Wentley, 2015).
The patient’s skin and mucosal
membranes require examination for
breaks in integrity or ulcerations
accompanied by signs of edema,
drainage, erythema, and tenderness
always remembering that these signs
and symptoms of infection may be
muted or absent due to altered immune
response related to the patient’s
neutropenia (Vioral & Wentley, 2015).

•

Patients should be educated on the
necessity and timing of the
administration of preventative
vaccinations such as the influenza and
pneumococcal vaccines. Vioral and
Wentley (2015) recommended that
patients complete vaccinations at
least two weeks prior to the beginning
of chemotherapeutic medications.
Infection prevention measures that
nurses should discuss with patients at
high risk for neutropenia include the
use of only electric razors for shaving,
use of soft toothbrushes and
importance of frequent oral care (at
least three to four times daily),
meticulous skin care (emphasizing
the importance of good hand
hygiene), proper central venous
access device care, perianal cleansing
after toileting, safe food handling and
preparation, refraining from cleaning
up animal excreta, avoiding contact
with soil or plants, refraining from
contact with people who have
received recent live vaccines, and
avoidance of anyone with colds,
respiratory infections, and/or large
crowds of people (Vioral & Wentley,
2015).
Patients should be educated on the
importance of monitoring their
temperature multiple times daily and
reporting any fever of 101 degrees
Fahrenheit or persistent fevers
greater than or equal to 100.4 degrees
Fahrenheit to their healthcare
provider. Education should also
include signs and symptoms of
infection such as redness, warmth,
edema, and tenderness. Should
preventative measures fail to provide
adequate protection against infection,
and concern for infection arises, it is
important that nurses educate
patients on when to seek medical
assistance.

•

•

•

•

•

•

Hawley, Loney, and Wiece (2011)
stressed that “…nurses need to
offer patients tangible education
and take-home tools to reinforce
what to do when potentially
neutropenic to minimize delays in
seeking medical attention and the
risk of life-threating sepsis” (p.
E53).
When febrile neutropenia is
suspected or confirmed,
hospitalization is warranted and
management requires rapid
initiation of sepsis protocols to
improve patient outcomes.
Nurses should anticipate that
neutropenic patients with
suspected sepsis will need to have
lactate levels and blood cultures
obtained (additional cultures such
as urine, sputum, and stool may
also be collected), aggressive fluid
resuscitation will be initiated, and
broad spectrum antibiotics will be
administered within three hours of
presentation to the department
(O’Leary, 2014).
The removal of indwelling
catheters should be requested and
preformed when there is suspicion
of catheter related bloodstream
infections (Legrand et al., 2012).
Frequent monitoring of patient
vital signs and continued physical
assessments are important to
assess patient response to
treatment (Held-Warmkessel,
2011).
When aggressive fluid
resuscitation fails to restore
hemodynamic stability and the
need for the administration of
vasopressors arises, nurses should
advocate for patients to be
transferred to intensive care units
for closer monitoring.

Conclusion
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Neutropenia in patients receiving chemotherapeutic medications for the
treatment of cancer can place patients at risk for potentially life threatening
immune dysfunction. Prevention of infection, early detection of symptoms, and
prompt intervention when concerns for infection arise are vital for positive
patient outcomes. Vioral and Wentley (2015) noted that “nurses are integral in
the prevention, identification, treatment, and management of these high
mortality complications of immunosuppressive therapies” (p. 173). Ensuring
that clinicians are well versed in their understanding of the pathophysiologic
process and implications for nursing care further contribute to improvements in
the quality of care received by the neutropenic patient.
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